2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or …

GYH Lip, JP Collet, M Haude, R Byrne, EH Chung… - Ep …, 2019 - academic.oup.com
In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

Surgical or transcatheter aortic-valve replacement in intermediate-risk patients

MJ Reardon, NM Van Mieghem… - New England journal …, 2017 - Mass Medical Soc
Background Although transcatheter aortic-valve replacement (TAVR) is an accepted
alternative to surgery in patients with severe aortic stenosis who are at high surgical risk …

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis

GCM Siontis, P Overtchouk, TJ Cahill… - European heart …, 2019 - academic.oup.com
Aims Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients
with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials

Y Ahmad, JP Howard, AD Arnold… - European Heart …, 2023 - academic.oup.com
Aims Additional randomized clinical trial (RCT) data comparing transcatheter aortic valve
implantation (TAVI) with surgical aortic valve replacement (SAVR) is available, including …

Transcatheter aortic valve implantation: current status and future perspectives

TJ Cahill, M Chen, K Hayashida, A Latib… - European heart …, 2018 - academic.oup.com
In the 16 years since the first pioneering procedure, transcatheter aortic valve implantation
(TAVI) has come of age and become a routine strategy for aortic valve replacement …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

Impact of Sapien 3 balloon-expandable versus Evolut R self-expandable transcatheter aortic valve implantation in patients with aortic stenosis: data from a nationwide …

P Deharo, A Bisson, J Herbert, T Lacour… - Circulation, 2020 - Am Heart Assoc
Background: Two competing transcatheter aortic valve replacement (TAVR) technologies
are currently available. Head-to-head comparisons of the relative performances of these 2 …